BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 15972430)

  • 1. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
    Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S
    AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
    Kim HJ; Kim KW; Byun JH; Won HJ; Shin YM; Kim PN; Lee MS; Lee MG
    AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT.
    Schima W; Függer R; Schober E; Oettl C; Wamser P; Grabenwöger F; Ryan JM; Novacek G
    AJR Am J Roentgenol; 2002 Sep; 179(3):717-24. PubMed ID: 12185052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography.
    Lee VS; Krinsky GA; Nazzaro CA; Chang JS; Babb JS; Lin JC; Morgan GR; Teperman LW
    Radiology; 2004 Dec; 233(3):659-66. PubMed ID: 15516606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
    Regge D; Campanella D; Anselmetti GC; Cirillo S; Gallo TM; Muratore A; Capussotti L; Galatola G; Floriani I; Aglietta M
    Clin Radiol; 2006 Apr; 61(4):338-47. PubMed ID: 16546464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET.
    Kalva SP; Sahani DV; Ryan D; Fischman AJ; Hahn PF; Mueller P; Saini S
    Acad Radiol; 2005 May; 12 Suppl 1():S17-20. PubMed ID: 16106540
    [No Abstract]   [Full Text] [Related]  

  • 8. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of liver metastases in patients with adenocarcinomas of the gastrointestinal tract: comparison of (18)F-FDG PET/CT and MR imaging.
    Maegerlein C; Fingerle AA; Souvatzoglou M; Rummeny EJ; Holzapfel K
    Abdom Imaging; 2015 Jun; 40(5):1213-22. PubMed ID: 25348732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small (Kim KW; Kim AY; Kim TK; Park SH; Kim HJ; Lee YK; Park MS; Ha HK; Kim PN; Kim JC; Lee MG
    AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer.
    Romijn MG; Stoker J; van Eijck CH; van Muiswinkel JM; Torres CG; Laméris JS
    J Magn Reson Imaging; 2000 Aug; 12(2):261-8. PubMed ID: 10931589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
    Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
    Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic enhancement and pulse sequence analysis using low-dose mangafodipir trisodium.
    Mayo-Smith WW; Schima W; Saini S; Slater GJ; McFarland EG
    AJR Am J Roentgenol; 1998 Mar; 170(3):649-52. PubMed ID: 9490946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretin-stimulated multi-detector CT versus mangafodipir trisodium-enhanced MR imaging plus MRCP in characterization of non-metastatic solid pancreatic lesions.
    Boraschi P; Donati F; Gigoni R; Salemi S; Faggioni L; Del Chiaro M; Boggi U; Bartolozzi C; Falaschi F
    Dig Liver Dis; 2009 Nov; 41(11):829-37. PubMed ID: 19303825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mangafodipir trisodium-enhanced magnetic resonance cholangiography for detection of bile leaks].
    Assaban M; Aubé C; Lebigot J; Ridereau-Zins C; Hamy A; Caron C
    J Radiol; 2006 Jan; 87(1):41-7. PubMed ID: 16415779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ; Kim MJ; Kim KW
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).
    Servois V; Mariani P; Malhaire C; Petras S; Piperno-Neumann S; Plancher C; Levy-Gabriel C; Lumbroso-le Rouic L; Desjardins L; Salmon RJ
    Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.
    Kong G; Jackson C; Koh DM; Lewington V; Sharma B; Brown G; Cunningham D; Cook GJ
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1323-9. PubMed ID: 18347794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs.
    Jung G; Heindel W; Krahe T; Kugel H; Walter C; Fischbach R; Klaus H; Lackner K
    Magn Reson Imaging; 1998 Oct; 16(8):925-31. PubMed ID: 9814775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.